CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$56.00 +1.91 (+3.53%)
At close: Sep 29, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) Operating Leases (2019 - 2026)

Updated

CRISPR Therapeutics AG (CRSP) posted Operating Leases of $178.9 million for Q2 2026, down 9.4% from $197.43 million a year earlier and down 2.5% from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Operating Leases (2019 - 2026) Analysis & Trends

At the end of FY2025, CRISPR Therapeutics AG's Operating Leases came in at $188.17 million, down 8.8% from FY2024.

  • Annual Operating Leases has declined for three consecutive years, though with a five-year compound annual growth rate of 30.3% (FY2020 to FY2025).
  • In prior years, CRISPR Therapeutics AG's Operating Leases was $206.41 million in FY2024 (-7.4%), $223.01 million in FY2023 (-2.3%), $228.18 million in FY2022 (+7.2%) and $212.87 million in FY2021 (+325.2%).
  • The Q2 2026 figure stands as the lowest quarterly Operating Leases since Q2 2021.
  • On a year-over-year basis, Operating Leases has declined in each of the last 14 quarters, with an average decline of 8.3% over the last eight quarters.
  • The strongest year-over-year quarter for Operating Leases in the past five years was Q3 2021, with growth of 399.7%; the weakest was Q2 2026, with a decline of 9.4%.
  • According to Business Quant data, Operating Leases for the three prior quarters was $183.56 million (Q1 2026), $188.17 million (Q4 2025) and $192.77 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 CRISPR Therapeutics AG 5.23 Bn 5.23 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 178.90 Mn
Mar 31, 2026 183.56 Mn
Dec 31, 2025 188.17 Mn
Sep 30, 2025 192.77 Mn
Jun 30, 2025 197.43 Mn
Mar 31, 2025 201.85 Mn
Dec 31, 2024 206.41 Mn
Sep 30, 2024 210.66 Mn
Jun 30, 2024 214.85 Mn
Mar 31, 2024 218.94 Mn
Dec 31, 2023 223.01 Mn
Sep 30, 2023 226.59 Mn
Jun 30, 2023 230.34 Mn
Mar 31, 2023 224.55 Mn
Dec 31, 2022 228.18 Mn
Sep 30, 2022 230.90 Mn
Jun 30, 2022 234.16 Mn
Mar 31, 2022 227.90 Mn
Dec 31, 2021 212.87 Mn
Sep 30, 2021 192.73 Mn
API Access

CRISPR Therapeutics AG Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=CRSP&period=max&api_key=YOUR_API_KEY